North America Cranial Implants Market Report 2021-2031 by Scope, Segmentation, Dynamics, and Competitive Analysis

Description

List of Tables

The North America cranial implants market is projected to grow significantly, reaching approximately US$ 1,166.77 million by 2031, up from US$ 674.28 million in 2023, reflecting a compound annual growth rate (CAGR) of 7.1% from 2023 to 2031.

Executive Summary and Market Analysis

The cranial implants market in North America is divided into three main regions: the United States, Canada, and Mexico. Several factors are propelling the growth of this market, including a high incidence of traumatic brain injuries (TBI), an aging demographic, and advancements in medical technology. The increasing rates of accidents, sports-related injuries, and neurological disorders are driving the demand for cranial implants. Innovations in biocompatible materials, such as polyether ether ketone (PEEK) and titanium, along with the use of 3D printing for personalized solutions, are enhancing surgical outcomes. Companies in the sector are also focusing on innovation to make cranial implant procedures more effective and accessible.

Market Segmentation Analysis

The North America cranial implants market can be analyzed through various segments, including type, material, and application.

By Type: The market is categorized into parietal, frontal, occipital, temporal, and sphenoid implants. In 2023, parietal implants accounted for the largest market share.
By Material: The segmentation by material includes polymethyl methacrylate, polyether ether ketone, titanium, and others. Polyether ether ketone was the leading material in market share in 2023.
By End User: The end-user segmentation includes hospitals, trauma centers, and others, with hospitals holding the largest share in 2023.

Market Outlook

Traumatic brain injuries are a major public health issue, disrupting normal brain function due to external mechanical forces. Common causes of TBIs include falls, motor vehicle accidents, and sports injuries, predominantly affecting younger and older adults. TBIs can range from mild concussions to severe injuries that lead to long-term cognitive, physical, and emotional disabilities. A report from The Lancet Neurology Commissions in 2022 highlighted that TBIs are among the leading causes of injury-related death and disability, impacting 55 million individuals globally and costing over US$ 400 billion annually. In Canada, the Brain Injury Association of Waterloo-Wellington reports that TBIs occur in 500 out of 100,000 people each year, with over 6,000 patients becoming permanently disabled due to TBIs annually. The rising demand for effective treatment options, particularly cranial implants, is driven by the increasing incidence of TBIs. These implants are essential for treating severe head injuries, protecting the brain from further damage, and restoring the skull's protective function. As TBI cases continue to rise, the demand for cranial implants is expected to increase significantly in the coming years.

Country Insights

The North America cranial implants market is primarily composed of the US, Canada, and Mexico, with the US holding the largest market share in 2023. The growth in this region is attributed to the high prevalence of TBIs, an aging population, and the availability of advanced medical technologies. The increasing number of accidents, sports injuries, and neurological conditions further fuels the demand for cranial implants. Innovations in biocompatible materials and 3D printing technology are improving surgical outcomes and making procedures more effective and accessible.

Company Profiles

Key players in the North America cranial implants market include Stryker Corp, Zimmer Biomet Holdings Inc, Integra LifeSciences Holdings Corp, OsteoMed SA, Anatomics Pty Ltd, Matrix Surgical Holdings LLC, Calavera Surgical, Medtronic Plc, Xilloc Medical BV, Johnson & Johnson, evonos GmbH & Co. KG, B Braun SE, UAB Ortho Baltic, 3D Systems Corp, GPC Medical Ltd, Bioplate Inc, EUROS SAS, Biocomposites Ltd, Medprin Biotech GmbH, Kelyniam Global Inc, MedCAD, KLS Martin Group, and Longeviti Neuro Solutions LLC, among others. These companies are employing various strategies, including expansion, product innovation, and mergers and acquisitions, to enhance their product offerings and increase market share.

Product Code: BMIRE00031980

1. Introduction

1.1 Report Guidance
1.2 Market Segmentation

2. Executive Summary

2.1 Key Insights

3. Research Methodology

3.1 Secondary Research
3.2 Primary Research
- 3.2.1 Hypothesis formulation:
- 3.2.2 Macro-economic factor analysis:
- 3.2.3 Developing base number:
- 3.2.4 Data Triangulation:
- 3.2.5 Country level data:

4. North America Cranial Implants Market Landscape

4.1 Overview
4.2 PEST Analysis

North America Cranial Implants Market - Key Market Dynamics

4.3 North America Cranial Implants Market - Key Market Dynamics
4.4 Market Drivers
- 4.4.1 Increase in the Prevalence of Traumatic Brain Injuries
- 4.4.2 Surge in Elderly Populations
4.5 Market Restraints
- 4.5.1 Risk of Implant Failure
4.6 Market Opportunities
- 4.6.1 Advancements in 3D Printing with Incorporation of Original Multilayer Technology
4.7 Future Trends
- 4.7.1 Customized Implants
4.8 Impact of Drivers and Restraints:

5. North America Cranial Implants Market - Analysis

5.1 North America Cranial Implants Market Revenue (US$ Million), 2021-2031
5.2 North America Cranial Implants Market Forecast Analysis

6. North America Cranial Implants Market Analysis - by Type

6.1 Parietal
- 6.1.1 Overview
- 6.1.2 Parietal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.2 Frontal
- 6.2.1 Overview
- 6.2.2 Frontal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.3 Occipital
- 6.3.1 Overview
- 6.3.2 Occipital: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.4 Temporal
- 6.4.1 Overview
- 6.4.2 Temporal: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
6.5 Sphenoid
- 6.5.1 Overview
- 6.5.2 Sphenoid: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

7. North America Cranial Implants Market Analysis - by Material

7.1 Polymethyl Methacrylate
- 7.1.1 Overview
- 7.1.2 Polymethyl Methacrylate: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.2 Polyether Ether Ketone
- 7.2.1 Overview
- 7.2.2 Polyether Ether Ketone: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.3 Titanium
- 7.3.1 Overview
- 7.3.2 Titanium: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
7.4 Others
- 7.4.1 Overview
- 7.4.2 Others: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

8. North America Cranial Implants Market Analysis - by End User

8.1 Hospitals
- 8.1.1 Overview
- 8.1.2 Hospitals: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.2 Trauma Centers
- 8.2.1 Overview
- 8.2.2 Trauma Centers: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
8.3 Others
- 8.3.1 Overview
- 8.3.2 Others: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)

9. North America Cranial Implants Market - Country Analysis

9.1 North America
- 9.1.1 North America Cranial Implants Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.1 North America Cranial Implants Market - Revenue and Forecast Analysis - by Country
  - 9.1.1.2 United States: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.2.1 United States: North America Cranial Implants Market Share - by Type
    - 9.1.1.2.2 United States: North America Cranial Implants Market Share - by Material
    - 9.1.1.2.3 United States: North America Cranial Implants Market Share - by End User
  - 9.1.1.3 Canada: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.3.1 Canada: North America Cranial Implants Market Share - by Type
    - 9.1.1.3.2 Canada: North America Cranial Implants Market Share - by Material
    - 9.1.1.3.3 Canada: North America Cranial Implants Market Share - by End User
  - 9.1.1.4 Mexico: North America Cranial Implants Market - Revenue and Forecast, 2021-2031 (US$ Million)
    - 9.1.1.4.1 Mexico: North America Cranial Implants Market Share - by Type
    - 9.1.1.4.2 Mexico: North America Cranial Implants Market Share - by Material
    - 9.1.1.4.3 Mexico: North America Cranial Implants Market Share - by End User

10. Industry Landscape

10.1 Overview
10.2 Mergers and Acquisitions
10.3 Product Launch
10.4 Expansions and Other Strategic Developments

11. Company Profiles

11.1 Stryker Corp
- 11.1.1 Key Facts
- 11.1.2 Business Description
- 11.1.3 Products and Services
- 11.1.4 Financial Overview
- 11.1.5 SWOT Analysis
- 11.1.6 Key Developments
11.2 Zimmer Biomet Holdings Inc
- 11.2.1 Key Facts
- 11.2.2 Business Description
- 11.2.3 Products and Services
- 11.2.4 Financial Overview
- 11.2.5 SWOT Analysis
- 11.2.6 Key Developments
11.3 Integra LifeSciences Holdings Corp
- 11.3.1 Key Facts
- 11.3.2 Business Description
- 11.3.3 Products and Services
- 11.3.4 Financial Overview
- 11.3.5 SWOT Analysis
- 11.3.6 Key Developments
11.4 OsteoMed SA
- 11.4.1 Key Facts
- 11.4.2 Business Description
- 11.4.3 Products and Services
- 11.4.4 Financial Overview
- 11.4.5 SWOT Analysis
- 11.4.6 Key Developments
11.5 Anatomics Pty Ltd
- 11.5.1 Key Facts
- 11.5.2 Business Description
- 11.5.3 Products and Services
- 11.5.4 Financial Overview
- 11.5.5 SWOT Analysis
- 11.5.6 Key Developments
11.6 Matrix Surgical Holdings LLC
- 11.6.1 Key Facts
- 11.6.2 Business Description
- 11.6.3 Products and Services
- 11.6.4 Financial Overview
- 11.6.5 SWOT Analysis
- 11.6.6 Key Developments
11.7 Calavera Surgical
- 11.7.1 Key Facts
- 11.7.2 Business Description
- 11.7.3 Products and Services
- 11.7.4 Financial Overview
- 11.7.5 SWOT Analysis
- 11.7.6 Key Developments
11.8 Medtronic Plc
- 11.8.1 Key Facts
- 11.8.2 Business Description
- 11.8.3 Products and Services
- 11.8.4 Financial Overview
- 11.8.5 SWOT Analysis
- 11.8.6 Key Developments
11.9 Xilloc Medical BV
- 11.9.1 Key Facts
- 11.9.2 Business Description
- 11.9.3 Products and Services
- 11.9.4 Financial Overview
- 11.9.5 SWOT Analysis
- 11.9.6 Key Developments
11.10 Johnson & Johnson
- 11.10.1 Key Facts
- 11.10.2 Business Description
- 11.10.3 Products and Services
- 11.10.4 Financial Overview
- 11.10.5 SWOT Analysis
- 11.10.6 Key Developments
11.11 evonos GmbH & Co. KG
- 11.11.1 Key Facts
- 11.11.2 Business Description
- 11.11.3 Products and Services
- 11.11.4 Financial Overview
- 11.11.5 SWOT Analysis
- 11.11.6 Key Developments
11.12 B Braun SE
- 11.12.1 Key Facts
- 11.12.2 Business Description
- 11.12.3 Products and Services
- 11.12.4 Financial Overview
- 11.12.5 SWOT Analysis
- 11.12.6 Key Developments
11.13 UAB Ortho Baltic
- 11.13.1 Key Facts
- 11.13.2 Business Description
- 11.13.3 Products and Services
- 11.13.4 Financial Overview
- 11.13.5 SWOT Analysis
- 11.13.6 Key Developments
11.14 3D Systems Corp
- 11.14.1 Key Facts
- 11.14.2 Business Description
- 11.14.3 Products and Services
- 11.14.4 Financial Overview
- 11.14.5 SWOT Analysis
- 11.14.6 Key Developments
11.15 GPC Medical Ltd
- 11.15.1 Key Facts
- 11.15.2 Business Description
- 11.15.3 Products and Services
- 11.15.4 Financial Overview
- 11.15.5 SWOT Analysis
- 11.15.6 Key Developments
11.16 Bioplate Inc
- 11.16.1 Key Facts
- 11.16.2 Business Description
- 11.16.3 Products and Services
- 11.16.4 Financial Overview
- 11.16.5 SWOT Analysis
- 11.16.6 Key Developments
11.17 EUROS SAS
- 11.17.1 Key Facts
- 11.17.2 Business Description
- 11.17.3 Products and Services
- 11.17.4 Financial Overview
- 11.17.5 SWOT Analysis
- 11.17.6 Key Developments
11.18 Biocomposites Ltd
- 11.18.1 Key Facts
- 11.18.2 Business Description
- 11.18.3 Products and Services
- 11.18.4 Financial Overview
- 11.18.5 SWOT Analysis
- 11.18.6 Key Developments
11.19 Medprin Biotech GmbH
- 11.19.1 Key Facts
- 11.19.2 Business Description
- 11.19.3 Products and Services
- 11.19.4 Financial Overview
- 11.19.5 SWOT Analysis
- 11.19.6 Key Developments
11.20 Kelyniam Global Inc
- 11.20.1 Key Facts
- 11.20.2 Business Description
- 11.20.3 Products and Services
- 11.20.4 Financial Overview
- 11.20.5 SWOT Analysis
- 11.20.6 Key Developments
11.21 MedCAD
- 11.21.1 Key Facts
- 11.21.2 Business Description
- 11.21.3 Products and Services
- 11.21.4 Financial Overview
- 11.21.5 SWOT Analysis
- 11.21.6 Key Developments
11.22 KLS Martin Group
- 11.22.1 Key Facts
- 11.22.2 Business Description
- 11.22.3 Products and Services
- 11.22.4 Financial Overview
- 11.22.5 SWOT Analysis
- 11.22.6 Key Developments
11.23 Longeviti Neuro Solutions LLC
- 11.23.1 Key Facts
- 11.23.2 Business Description
- 11.23.3 Products and Services
- 11.23.4 Financial Overview
- 11.23.5 SWOT Analysis
- 11.23.6 Key Developments

12. Appendix

12.1 About Us
12.2 List of Abbreviations